Zhaoke Ophthalmology’s IND Application for Phase III Clinical Trial of NVK-002 for Myopia Treatment in China Accepted for Review by CDE

Zhaoke Ophthalmology’s Last Patient Completed Treatment for Phase III Clinical Trial of Cyclosporine A (CsA) Ophthalmic Gel for Dry Eye Disease, New Drug Application Planned Around the End of 2021

Podcast Series Episode 1: Myopia prevalence in children and adolescents and Zhaoke’s potential treatment solution

Zhaoke Ophthalmology Participated in the 21st Chinese International Congress of Ophthalmology and Optometry and Glaucoma Academic Exchange Advisory Meeting

Zhaoke Hong Kong and Nevakar Entered into an Exclusive Licensing Agreement for NVK-002